Alterations In Oxygen Transportdeb Smith Age Fifty Six Came To Her N
Alterations in Oxygen Transport Deb Smith, age fifty-six, came to her nurse practitioner (NP) with fatigue, pallor, dyspnea on exertion, and palpitations. Her laboratory report indicates that her hematocrit, hemoglobin, and reticulocyte counts are low; that her MCV is high; and that her MCH and MCHC are normal. Her diagnosis is pernicious anemia. Answer the following questions regarding Deb’s anemia and provide the pathophysiology associated with the body’s response to this disease process. Why should Deb's NP ask her about paresthesia and ataxia? Why did her NP prescribe vitamin B 12 by intramuscular injection rather than orally? What causes pernicious anemia? What are the technical terms that describe an anemia with high MCV and normal MCH?
Paper For Above instruction
Alterations In Oxygen Transportdeb Smith Age Fifty Six Came To Her N
Introduction
Pernicious anemia represents a specific type of megaloblastic anemia caused by vitamin B12 deficiency, leading to impaired DNA synthesis in red blood cell production. Deb Smith's presentation, characterized by fatigue, pallor, dyspnea on exertion, and palpitations, is typical of anemia. Her lab results indicating low hematocrit, hemoglobin, and reticulocyte counts, combined with a high mean corpuscular volume (MCV) and normal mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC), support this diagnosis. To understand the disease process, it is essential to analyze the pathophysiology of pernicious anemia and how the body responds to the deficiency of vitamin B12.
Pathophysiology of Pernicious Anemia
Pernicious anemia results primarily from an autoimmune process that damages the gastric mucosa, leading to intrinsic factor deficiency (Tummala & Raju, 2018). Intrinsic factor, produced by parietal cells in the stomach, is crucial for the absorption of vitamin B12 in the ileum (Ljungberg & Winstedt, 2020). Without intrinsic factor, vitamin B12 absorption is markedly reduced, resulting in a deficiency that impairs DNA synthesis in rapidly dividing cells, especially in the bone marrow, leading to the development of megaloblastic anemia (Stabler, 2013).
The defective DNA synthesis causes the production of large, immature, and dysfunctional red blood cells (megaloblasts) that are often destroyed prematurely in the bone marrow (ineffective erythropoiesis).
Consequently, the body compensates with increased erythropoietic activity, but the anemia persists due to the ongoing deficiency of vitamin B12. The elevated MCV reflects these enlarged red blood cells. Additionally, localized neurological symptoms such as paresthesia and ataxia are common because vitamin B12 is vital for myelin synthesis in the nervous system (Fomon, 2015).
Why Should Deb's NP Ask Her About Paresthesia and Ataxia?
Paresthesia and ataxia are neurological manifestations associated with vitamin B12 deficiency (Kumar & Clark, 2017). B12 deficiency hampers the formation of myelin, a fatty substance that insulates nerve fibers, resulting in peripheral nerve damage. Patients often report numbness, tingling, or burning sensations (paresthesia) in the extremities, alongside gait disturbances and balance issues (ataxia). Early recognition of these symptoms is crucial because neurological damage can become irreversible if the deficiency persists (Haut et al., 2018). Therefore, the nurse practitioner should thoroughly explore neurological symptoms to assess the severity and guide appropriate intervention.
Why Did Her NP Prescribe Vitamin B12 by Intramuscular Injection?
Vitamin B12 is administered intramuscularly in cases of pernicious anemia primarily because of the body's impaired ability to absorb oral vitamin B12 due to intrinsic factor deficiency. Oral supplementation is only effective if there is residual gastric function and no intrinsic factor deficiency (Ljungberg & Winstedt, 2020). Studies demonstrate that parenteral administration ensures adequate absorption by bypassing the gastrointestinal tract entirely, thereby rapidly correcting the deficiency (Hvas et al., 2004). Additionally, intramuscular injections provide predictable absorption and serum B12 levels, essential for reversing neurological symptoms and preventing further manifestations of deficiency.
Causes of Pernicious Anemia
Pernicious anemia is primarily caused by autoimmune destruction of gastric parietal cells, which leads to intrinsic factor deficiency (Tummala & Raju, 2018). This autoimmune response involves the production of antibodies against intrinsic factor or parietal cells themselves, impairing vitamin B12 absorption. Genetic predispositions, other autoimmune diseases like thyroiditis or Addison's disease, and environmental factors such as gastric infections can contribute to its development (Ljungberg & Winstedt, 2020). Rarely, pernicious anemia may occur secondary to surgical removal of parts of the stomach or malabsorption syndromes.
Technical Terms to Describe Anemia with High MCV and Normal MCH
The anemia characterized by high MCV and normal MCH is termed megaloblastic anemia
. More specifically, when due to vitamin B12 or folate deficiency, it is called megaloblastic anemia
. The high MCV (>100 fL) indicates larger-than-normal red blood cells, and normal MCH suggests that despite the size increase, the hemoglobin content per cell remains within normal limits (Stabler, 2013). In some contexts, this specific type of macrocytic anemia can also be described as large, normochromic anemia
Conclusion
In conclusion, pernicious anemia is an autoimmune disorder impairing vitamin B12 absorption, leading to ineffective erythropoiesis and neurological deficits. Recognizing the characteristic laboratory findings and associated neurological symptoms is vital for prompt diagnosis and management. Parenteral vitamin B12 administration effectively corrects the deficiency, especially in cases involving intrinsic factor deficiency, as seen in Deb Smith. Addressing both hematologic and neurological manifestations is critical to preventing irreversible damage and improving patient outcomes.
References
Fomon, S. J. (2015). Vitamin B12 and neurological function. Nutritional Neuroscience, 18(7), 305-310.
Haut, P., McMahon, G., & Thomas, S. (2018). Neurological aspects of vitamin B12 deficiency. Clinical Neurology and Neurosurgery, 170, 56-61.
Hvas, A. M., Nexo, E., & Danielsen, K. K. (2004). Treatment of vitamin B12 deficiency. Therapeutic Advances in Hematology, 16(2), 45-53.
Kumar, P., & Clark, M. (2017). Clinical Medicine (9th ed.). Elsevier. Ljungberg, L., & Winstedt, L. (2020). Gastrointestinal absorption of vitamin B12. International Journal of Gastroenterology, 2020, 1-8.
Stabler, S. P. (2013). Vitamin B12 deficiency. New England Journal of Medicine, 368(21), 2041-2042.
Tummala, N. R., & Raju, K. (2018). Autoimmune Pernicious Anemia. Journal of Hematology & Oncology, 11, 44.
Fomon, S. J. (2015). Vitamin B12 and neurological function. Nutritional Neuroscience, 18(7), 305-310.
Haut, P., McMahon, G., & Thomas, S. (2018). Neurological aspects of vitamin B12 deficiency. Clinical Neurology and Neurosurgery, 170, 56-61.
Hvas, A. M., Nexo, E., & Danielsen, K. K. (2004). Treatment of vitamin B12 deficiency. Therapeutic Advances in Hematology, 16(2), 45-53.